Related references
Note: Only part of the references are listed.The Spliceosome: Design Principles of a Dynamic RNP Machine
Markus C. Wahl et al.
CELL (2009)
Phase II Open Label Study of Valproic Acid in Spinal Muscular Atrophy
Kathryn J. Swoboda et al.
PLOS ONE (2009)
Stalling of spliceosome assembly at distinct stages by small-molecule inhibitors of protein acetylation and deacetylation
Andreas N. Kuhn et al.
RNA (2009)
Differential 3′ splice site recognition of SMN1 and SMN2 transcripts by U2AF and U2 snRNP
Mafalda Martins de Araujo et al.
RNA (2009)
Antisense masking of an hnRNP A1/A2 intronic splicing silencer corrects SMN2 splicing in Transgenic mice
Yimin Hua et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2008)
Substances that can change alternative splice-site selection
Chiranthani Sumanasekera et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2008)
Deciphering the assembly pathway of Sm-class U snRNPs
Nils Neuenkirchen et al.
FEBS LETTERS (2008)
Riboswitch RNAs: using RNA to sense cellular metabolism
Tina M. Henkin
GENES & DEVELOPMENT (2008)
The RNA Binding Protein hnRNP Q Modulates the Utilization of Exon 7 in the Survival Motor Neuron 2 (SMN2) Gene
Hung-Hsi Chen et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Salbutamol increases SMN mRNA and protein levels in spinal muscular atrophy cells
C. Angelozzi et al.
JOURNAL OF MEDICAL GENETICS (2008)
Riboswitch control of gene expression in plants by splicing and alternative 3′ end processing of mRNAs
Andreas Wachter et al.
PLANT CELL (2007)
Splicing factor SF3b as a target of the antitumor natural product pladienolide
Yoshihiko Kotake et al.
NATURE CHEMICAL BIOLOGY (2007)
Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA
Daisuke Kaida et al.
NATURE CHEMICAL BIOLOGY (2007)
Control of alternative RNA splicing and gene expression by eukaryotic riboswitches
Ming T. Cheah et al.
NATURE (2007)
Chaperoning ribonucleoprotein biogenesis in health and disease
Livio Pellizzoni
EMBO REPORTS (2007)
Enhancement of SMN2 Exon 7 inclusion by antisense oligonucleotides targeting the exon
Yimin Hua et al.
PLOS BIOLOGY (2007)
Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy
Amy M. Avila et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Therapeutic potential and mechanism of kinetin as a treatment for the human splicing disease familial dysautonomia
Matthew M. Hims et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2007)
Modulating role of RNA structure in alternative splicing of a critical exon in the spinal muscular atrophy genes
Natalia N. Singh et al.
NUCLEIC ACIDS RESEARCH (2007)
Tetracycline aptamer-controlled regulation of pre-mRNA splicing in yeast
Julia E. Weigand et al.
NUCLEIC ACIDS RESEARCH (2007)
Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number
B Wirth et al.
HUMAN GENETICS (2006)
Splicing of a critical exon of human survival motor neuron is regulated by a unique silencer element located in the last intron
NK Singh et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Determinants of exon 7 splicing in the spinal muscular atrophy genes, SMN1 and SMN2
L Cartegni et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
Alternative splicing: A new drug target of the post-genome era
M Hagiwara
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2005)
The spliceosome: a novel multi-faceted target for therapy
J Tazi et al.
TRENDS IN BIOCHEMICAL SCIENCES (2005)
Diverse small-molecule modulators of SMN expression found by high-throughput compound screening: early leads towards a therapeutic for spinal muscular atrophy
J Jarecki et al.
HUMAN MOLECULAR GENETICS (2005)
Selective modification of alternative splicing by indole derivatives that target serine-arginine-rich protein splicing factors
J Soret et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Serine/arginine-rich protein-dependent suppression of exon skipping by exonic splicing enhancers
EC Ibrahim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Indoprofen upregulates the survival motor neuron protein through a cyclooxygenase-independent mechanism
MR Lunn et al.
CHEMISTRY & BIOLOGY (2004)
Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy
L Brichta et al.
HUMAN MOLECULAR GENETICS (2003)
A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy
T Kashima et al.
NATURE GENETICS (2003)
Versatile and facile synthesis of diverse semisynthetic tetracycline derivatives via Pd-catalyzed reactions
ML Nelson et al.
JOURNAL OF ORGANIC CHEMISTRY (2003)
Pre-mRNA splicing: Awash in a sea of proteins
MS Jurica et al.
MOLECULAR CELL (2003)
Teaching TetR to recognize a new inducer
O Scholz et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
Inverse correlation between SMN1 and SMN2 copy numbers:: evidence for gene conversion from SMN2 to SMN1
S Ogino et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2003)
Correction of disease-associated exon skipping by synthetic exon-specific activators
L Cartegni et al.
NATURE STRUCTURAL BIOLOGY (2003)
Valproic acid increases SMN levels in spinal muscular atrophy patient cells
CJ Sumner et al.
ANNALS OF NEUROLOGY (2003)
hnRNP-G promotes exon 7 inclusion of survival motor neuron (SMN) via direct interaction with Htra2-β1
Y Hofmann et al.
HUMAN MOLECULAR GENETICS (2002)
The molecular bases of spinal muscular atrophy
T Frugier et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2002)
Quantitative analyses of SMN1 and SMN2 based on real-time LightCycler PCR:: Fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy
M Feldkötter et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2002)
SRp30c-dependent stimulation of survival motor neuron (SMN) exon 7 inclusion is facilitated by a direct interaction with hTra2 beta 1
PJ Young et al.
HUMAN MOLECULAR GENETICS (2002)
Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients
C Andreassi et al.
HUMAN MOLECULAR GENETICS (2001)
Targeting RNA with small-molecule drugs: Therapeutic promise and chemical challenges
J Gallego et al.
ACCOUNTS OF CHEMICAL RESEARCH (2001)
Pre-mRNA splicing in the new millennium
ML Hastings et al.
CURRENT OPINION IN CELL BIOLOGY (2001)
Tetracycline antibiotics: Mode of action, applications, molecular biology, and epidemiology of bacterial resistance
I Chopra et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2001)
Animal models of spinal muscular atrophy
UR Monani et al.
HUMAN MOLECULAR GENETICS (2000)
Htra2-β1 stimulates an exonic splicing enhancer and can restore full-length SMN expression to survival motor neuron 2 (SMN2)
Y Hofmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn-/- mice and results in a mouse with spinal muscular atrophy
UR Monani et al.
HUMAN MOLECULAR GENETICS (2000)
A mouse model for spinal muscular atrophy
HM Hsieh-Li et al.
NATURE GENETICS (2000)
Share Paper
